newsfilter
← Latest News
PR Newswire·

Halozyme to Report Third Quarter 2026 Financial and Operating Results

SAN DIEGO, Oct. 22, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme") today announced it will release its third quarter 2026 financial and operating results on Thursday, November 5,